A study on the efficacy of osimertinib as the second-line treatment for patients with EGFR-mutant advanced non-small cell lung cancer
SHI Yue
JIANG Yingying
CHEN Jin
SHI Yumeng
CHEN Qianying
TIAN Haixia
CHEN Cheng
SHI Meiqi
SHEN Bo
ZHOU Guoren
WANG Xiaohua
FENG Jifeng
Machine-generated Keywords：
Publication Date：2022-03-28
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：6( 221-226 )